Intubation is required for patients whose airways are damaged or who are unable to breathe spontaneously. Circumstances necessitating this procedure include cardiac arrest, airway obstruction, loss of consciousness, neck injuries, and respiratory failure. Surgery under general anesthesia also routinely requires intubation. However, risks accompany the procedure, including airway irritation and narrowing that can cause post-procedure breathing difficulties. Corticosteroids may be administered alongside intubation to mitigate these risks and enhance patient comfort.
Extubation following prolonged intubation carries the risk of post-intubation tracheal stenosis - airway narrowing. Though relatively uncommon, this condition can be severe, extending ICU stays and sometimes requiring re-intubation. Practitioners commonly take preventive measures to reduce the risk of stridor during necessary intubation and extubation.
Corticosteroid administration via intravenous dexamethasone injection represents a preventive measure leveraging anti-inflammatory properties. A 2009 meta-analysis examining randomized controlled trials revealed significant improvement in preventing re-intubation and post-intubation stridor in adults when multiple doses of corticosteroid were administered 12-24 hours prior to extubation. However, effectiveness was not demonstrated in neonates or children, and single-dose administration proved ineffective.
A 2023 review article by Feng et al. compared various corticosteroids' efficacy in preventing post-extubation complications. The analysis found that methylprednisolone and dexamethasone are the most potent in preventing these undesirable post-extubation outcomes. Conversely, hydrocortisone proved ineffective. These findings enable physicians to better mitigate post-intubation inflammatory risks and establish evidence-based preventative practice standards.